Back

Topical antimitotic treatments for plantar warts are more beneficial: A Bayesian network meta‐analysis of randomized controlled trials.

  • Published In: Journal of Evidence-Based Medicine, 2024, v. 17, n. 1. P. 37 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Xu, Yantao; Wang, Ying; Huang, Kai; Huang, Weihong; Zhao, Shuang; Jiang, Zixi 3 of 3

Abstract

Background: Plantar warts are common infectious cutaneous growths causing severe physiological and psychological discomforts in patients and heaving global financial burdens. However, paucity of clear‐cut guidelines for plantar warts, selecting appropriate treatments for plantar warts remains challenging. The objective of the study is to evaluate the efficacy and safety of common treatments for plantar warts. Methods: PubMed, EMbase, and The Cochrane Library were searched from inception to March 1, 2023 for randomized controlled trials (RCTs) of plantar warts. The primary outcome (complete response) and secondary outcome (recurrence and pain) were extracted and combined using Bayesian network meta‐analysis (NMA) with random‐effect and fixed‐effect models. Results: Totally, 33 RCTs were included in the systematic review and quantitative NMA. In NMA of complete response, topical application of 1% cantharidin, 20% podophylotoxin, 30% salicylic acid (CPS), microneedles plus bleomycin (MNB), and intralesional bleomycin injection (INB) were the only three treatments significantly superior to no treatment (NT) and CPS was of the highest possibility to be the top‐ranked treatment (SUCRA = 0.9363). However, traditional warts treatments, salicylic acid (SA) and cryotherapy were not superior to NT. Conclusions: The NMA has produced evidence for using CPS, MNB, and INB, which are all topical antimitotic treatments, to improve the management of plantar warts. The classic treatment modalities for plantar warts, including SA and cryotherapy, may play a less important role in the clinical practice of plantar warts. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Journal of Evidence-Based Medicine. 2024/03, Vol. 17, Issue 1, p37
  • Document Type:Article
  • Subject Area:Complementary and Alternative Medicine
  • Publication Date:2024
  • ISSN:1756-5383
  • DOI:10.1111/jebm.12586
  • Accession Number:176335460
  • Copyright Statement:Copyright of Journal of Evidence-Based Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.